These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 30238023)

  • 1. Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.
    Greenwald MK
    Neurobiol Stress; 2018 Nov; 9():84-104. PubMed ID: 30238023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.
    Koob GF
    Pharmacol Rev; 2021 Jan; 73(1):163-201. PubMed ID: 33318153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kappa agonist-induced reinstatement of cocaine seeking in squirrel monkeys: a role for opioid and stress-related mechanisms.
    Valdez GR; Platt DM; Rowlett JK; Rüedi-Bettschen D; Spealman RD
    J Pharmacol Exp Ther; 2007 Nov; 323(2):525-33. PubMed ID: 17702903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic stress, drug use, and vulnerability to addiction.
    Sinha R
    Ann N Y Acad Sci; 2008 Oct; 1141():105-30. PubMed ID: 18991954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for brain stress systems in addiction.
    Koob GF
    Neuron; 2008 Jul; 59(1):11-34. PubMed ID: 18614026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy of addictive disorders.
    Ross S; Peselow E
    Clin Neuropharmacol; 2009; 32(5):277-89. PubMed ID: 19834993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Novel Metabotropic Glutamate Receptor 2 Positive Allosteric Modulator, AZD8529, Decreases Nicotine Self-Administration and Relapse in Squirrel Monkeys.
    Justinova Z; Panlilio LV; Secci ME; Redhi GH; Schindler CW; Cross AJ; Mrzljak L; Medd A; Shaham Y; Goldberg SR
    Biol Psychiatry; 2015 Oct; 78(7):452-62. PubMed ID: 25802079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.
    Zaveri NT
    Curr Top Med Chem; 2011; 11(9):1151-6. PubMed ID: 21050175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
    Nazzaro C; Marino S; Barbieri M; Siniscalchi A
    Neurochem Int; 2009; 54(5-6):378-84. PubMed ID: 19418633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologically-induced stress: a cross-species probe for translational research in drug addiction and relapse.
    See RE; Waters RP
    Am J Transl Res; 2010 Oct; 3(1):81-9. PubMed ID: 21139808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.
    Negus SS; Banks ML
    Pharmacol Biochem Behav; 2018 Jan; 164():32-39. PubMed ID: 28442370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission.
    Domi E; Caputi FF; Romualdi P; Domi A; Scuppa G; Candeletti S; Atkins A; Heilig M; Demopulos G; Gaitanaris G; Ciccocioppo R; Ubaldi M
    J Neurosci; 2019 Dec; 39(49):9864-9875. PubMed ID: 31685649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
    Heilig M; Egli M
    Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel approaches to the treatment of cocaine addiction.
    Sofuoglu M; Kosten TR
    CNS Drugs; 2005; 19(1):13-25. PubMed ID: 15651902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
    Heilig M
    J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors.
    Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR
    Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.